Mai Hung Nguyen, - Pharmacist in Las Vegas, NV

Mai Hung Nguyen, is a Pharmacist based in Las Vegas, Nevada. Mai Hung Nguyen is licensed to practice in Nevada (license number 16596) and his current practice location is 2389 E Windmill Ln, Las Vegas, Nevada. He can be reached at his office (for appointments etc.) via phone at (702) 837-2060.

NPI number for Mai Hung Nguyen is 1003199472 and his current mailing address is 2389 E Windmill Ln, Las Vegas, Nevada. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1003199472.

Contact Information

Mai Hung Nguyen,
2389 E Windmill Ln,
Las Vegas, NV 89123-2037
(702) 837-2060
Not Available

Healthcare Provider's Profile

Full NameMai Hung Nguyen
GenderMale
SpecialityPharmacist
Location2389 E Windmill Ln, Las Vegas, Nevada
Accepts Medicare AssignmentsDoes not participate in Medicare Program. He may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1003199472
  • Provider Enumeration Date: 09/22/2011
  • Last Update Date: 09/24/2011

Medical Identifiers

Medical identifiers for Mai Hung Nguyen such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1003199472NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
183500000XPharmacist 16596 (Nevada)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mai Hung Nguyen is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Mai Hung Nguyen,
2389 E Windmill Ln,
Las Vegas, NV 89123-2037

Ph: (702) 837-2060
Mai Hung Nguyen,
2389 E Windmill Ln,
Las Vegas, NV 89123-2037

Ph: (702) 837-2060

News Archive

Genentech and Biogen Idec announce positive results from ocrelizumab phase II RRMS study

Genentech, Inc., a member of the Roche Group, and Biogen Idec today announced 24-week results from a phase II study of ocrelizumab in patients with relapsing-remitting multiple sclerosis (RRMS), the most common form of the disease. Ocrelizumab demonstrated a significant reduction in disease activity as measured by brain lesions and relapse rate.

Hospitals' rocky rollout of covid vaccine sparks questions of fairness

Last week, after finishing inoculations of some front-line hospital staff, Jupiter Medical Center was left with 40 doses of precious covid vaccine. So, officials offered shots to the South Florida hospital's board of directors and their spouses over age 65.

Preclinical data in neuroblastoma for perifosine to be presented at AACR 2010 Meeting

Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that preclinical data in neuroblastoma for perifosine, the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase pathway, will be presented at the 101st Annual Meeting of the American Association for Cancer Research, currently being held at the Walter E. Washington Convention Center in Washington, DC.

Research finding suggests possibilities for future treatment of anxiety disorders

Researchers at the University of Puerto Rico, School of Medicine have found a way to pharmacologically induce a memory of safety in the brain of rats. As reported in the June, 4 2010 issue of Science, administering brain-derived neurotrophic factor into the prefrontal cortex prevented rats from expressing fear to a tone that had been previously paired with a shock.

HealthCare.com launches new health insurance comparison website

HealthCare.com announces the launch of its new health insurance comparison website that gives consumers more choices to research, shop and buy healthcare plans, which could lead to lowering insurance costs for millions of Americans.

Read more News

› Verified 4 days ago


Pharmacist in Las Vegas, NV

Stan Wilson Sadler,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 6450 Sky Pointe Dr, Las Vegas, NV 89131
Phone: 702-515-1821    Fax: 702-515-1839
Matt Weeks, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 9300 W Sahara Ave, Las Vegas, NV 89117
Phone: 702-228-2480    Fax: 702-228-8589
Dr. Karen Alspector, PHARM.D
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1144 E Charleston Blvd, Las Vegas, NV 89104
Phone: 702-382-7373    Fax: 702-382-5927
Monna Marie Valle,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 6485 S Fort Apache Rd, Las Vegas, NV 89148
Phone: 702-262-1247    
Thomas Enrico Grande, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 8579 S Eastern Ave, Suite B, Las Vegas, NV 89123
Phone: 702-792-3777    
Medhat N Mansy, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 821 N Lamb Blvd Ste 4, Las Vegas, NV 89110
Phone: 725-465-7770    Fax: 725-465-7771

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.